Vyndamax 61 MG capsule UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9T27
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,185
Award facts
- Contract value 100% obligated
- $29,185.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $29,185.16 for VYNDAMAX 61 mg capsule unit dose packages (30-count) on December 30, 2025, with completion targeted for January 22, 2026. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this pharmaceutical supply delivery. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.999 billion ceiling through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen is a major pharmaceutical distributor and critical federal medical procurement vendor supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military and veteran healthcare systems. The parent SPE2DX IDC enables the company to fulfill diverse pharmaceutical needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA Troop Support is planning successor Pharmaceutical Prime Vendor Global Program Generation V contracts with anticipated multiple regional awards, positioning AmerisourceBergen competitively within the evolving federal pharmaceutical supply landscape.
Quick answers
Who was awarded contract SPE2DR26F9T27?
SPE2DR26F9T27 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26F9T27 worth?
The government has obligated $29,185 on SPE2DR26F9T27.
Is contract SPE2DR26F9T27 an order under another contract?
Yes. SPE2DR26F9T27 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9T27 competed?
The extent of competition for SPE2DR26F9T27 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award